To our knowledge, there are no data that describe the action of EBNA2 at these cis-acting elements during the very first days of infection, but our data suggest that EBNA2 acts on the MYC locus and its upstream enhancers initially, when EBV infects quiescent primary B lymphocytes. The gene discussed is MYC; the disease is infection.